Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiological and clinical features of lung cancer patients from 1999 to 2009 in Tokushima Prefecture of Japan.
Kanematsu T, Hanibuchi M, Tomimoto H, Sakiyakma S, Kenzaki K, Kondo K, Bando H, Haku T, Yoneda K, Hirose T, Toyoda Y, Goto H, Sakaguchi S, Kinoshita K, Azuma M, Kakiuchi S, Kishi J, Azuma M, Tada H, Sumitomo M, Nishioka Y, Yano S, Sone S. Kanematsu T, et al. Among authors: kakiuchi s. J Med Invest. 2010 Aug;57(3-4):326-33. doi: 10.2152/jmi.57.326. J Med Invest. 2010. PMID: 20847534 Free article.
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer.
Tomimoto H, Hanibuchi M, Ogushi F, Okano Y, Shinohara T, Doi H, Yamamoto A, Takeuchi E, Yamamoto A, Azuma M, Tada H, Kanematsu T, Kakiuchi S, Goto H, Yano S, Nishioka Y, Sone S. Tomimoto H, et al. Among authors: kakiuchi s. Oncol Lett. 2011 May;2(3):465-470. doi: 10.3892/ol.2011.266. Epub 2011 Mar 10. Oncol Lett. 2011. PMID: 22866104 Free PMC article.
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.
Goto H, Okano Y, Machida H, Hatakeyama N, Ogushi F, Haku T, Kanematsu T, Urata T, Kakiuchi S, Hanibuchi M, Sone S, Nishioka Y. Goto H, et al. Among authors: kakiuchi s. Respir Investig. 2018 Jan;56(1):80-86. doi: 10.1016/j.resinv.2017.09.003. Epub 2017 Oct 21. Respir Investig. 2018. PMID: 29325686 Clinical Trial.
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease.
Hanibuchi M, Kakiuchi S, Atagi S, Ogushi F, Shimizu E, Haku T, Toyoda Y, Azuma M, Kondo M, Kawano H, Otsuka K, Sakaguchi S, Nokihara H, Goto H, Nishioka Y. Hanibuchi M, et al. Among authors: kakiuchi s. Lung Cancer. 2018 Nov;125:93-99. doi: 10.1016/j.lungcan.2018.09.007. Epub 2018 Sep 12. Lung Cancer. 2018. PMID: 30429044 Clinical Trial.
225 results